Transplantation Flashcards

1
Q

In general terms, what is the function of the immune system?

A

Normal immune system function
Protection from non-self - pathogens
Protection from abnormal self – e.g. tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some key players in the innate and adaptive immune system?

A

Innate immune system
Macrophages
Neutrophils
Complement & natural antibodies (IgM)

Adaptive immune system
Dendritic cells (antigen presentation)
T cells (helper and cytotoxic T cells)
Natural Killer (NK) cells - cytotoxic
B cells (antibody generation & memory)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the major histocompatibility complex (MHC)?

A

MHC in humans is called Histocompatibility Locus Antigen (HLA)

These molecules help the immune system to recognise ‘self’ and also to intiate immune responses.

HLA genes are very polymorphic i.e. there are many different variations possible at each gene locus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the two classes of HLA molecules? Where are they found?

A

Two broad categories

Class I - HLA-A, B and C – expressed by most somatic cells – present peptides from internally processed proteins – allows immune cells to check the health of our cells - e.g. virus proteins can be presented and recognised by T-cells for killing.

Class II – HLA-DP, -DQ and –DR - expressed on APCs – sampling their microenvironment – presenting peptides from digested material including pathogens, abnormal or foreign cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Apart from T-Cell receptor-HLA interactions, are other signals also required for T-cell activation?

A

T-cell synapse – other molecules need to be present to ensure the signal is strong enough to trigger an immune response (APCs interacting with T-cell) – Co-stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Are cytotoxic T-cells good killers? How do they carry out the deed?

A

Cytotoxic cell is a very effective killer
- Fas-Ligand, TNF-a, granzyme and perforin (punch wholes in membranes) – drives apoptosis of target cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Outline in general terms how naive T-cells can become activated?

A

Dendritic cell pick up abnormal molecule – present to T-cell (antigen specific) – stimulated by IL-2 (T-cell proliferation) – leading to the clonal expansion of T-cell army – circulate body to exert function

Don’t want this to continue forever – activation induced cell death – but we are left with memory T-cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are 4 key principles of transplant immunology?

A
  • Rejection of transplanted organs is directed at specific protein - antigens
  • Rejection is donor specific – specific to the donor
  • Rejection may be both cell or antibody mediated
  • Rejection exhibits memory– 2nd similar transplant is rejected more rapidly – rapid generation of cytotoxic antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is HLA profiling?

A

If we transplant an organ we want to know the HLA-profile of the donor so that we can match it the best way possible with the recipient.

Longer term surivival increases with fewer mismatches.

Performed using molecular biological and serological techniques

The HLA tissue types of all patients on the Kidney Transplant waiting list is held on a central UK database and the ‘best match’ chosen when kidneys become available

Notation
* If all HLA-A, -B and –DR loci are the same the it is a 0-0-0 mismatch
* If they are all different then it is a 2-2-2 mismatch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Is HLA profiling equally important for both kidney and liver transplants?

A

Used to allocate kidneys but less important for other organs such as liver (less immunogenic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What immunosuppresant treatments do we use when performing a organ transplant?

A

Corticosteroids – kill lymphocytes, interfere with T-cell activation/gene transcription and it is a very anti-inflammatory agent

Calcineurin inhibitors (tacrolimus) – inhibit T-cell activation – targeting intracellular pathways

Anti-proliferative agents - mycophenolate mofetil (MMF) - Inhibit clonal expansion of T cells.

Various monoclonal and polyclonal antibodies directed against:
* IL-2 receptor blockers (IL-2 stimulates clonal expansion of T cells)
* T cells (cytotoxic complement fixing Abs) – kill them
* Co-stimulatory molecules – target co-stimulatory molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some examples of transplantable organs/tissues?

A
  • Kidney
  • Pancreas (complete organ or pancreatic islets)
  • Liver
  • Lung
  • Heart
  • Small Bowel
  • Cornea
  • Faces, arms etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What things do we consider when assessing a patient for a kidney transplant?

A

Patient assessed in specific transplant clinic

  • Age is important – not as much chronological but more interested in biological age
  • Cause of Kidney failure
  • Kidney failure due to polycystic kidney disease can’t recur in a transplant
  • Whereas Atypical Haemolytic Uraemic and Focal segmental glomerular sclerosis – always or highly likely to recur
  • Comorbid disease very important – cardiovascular (IHD or PVD) and diabetes
  • History of Infections are important to consider as you’ll be immunosuppressing the patient
  • History of tumours - need a tumour free period – depending on the type of tumour
  • Urological disease – as the kidney will be connected into the urological system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What additional investigations can be performed prior to a renal transplant?

A
  • CARDIAC - exercise ECG, myocardial perfusion studies
  • Angiography (need decent vessels for the anastomosis)
  • Urodynamic studies
  • Tumour markers, imaging etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the two main types of donor when in comes to transplantation?

A

Cadaveric Transplant (commonest) e.g. subarachnoid haemorrhage
* DCD = donated after cardiac death
* DBD = donation after brain death

Living related donor Tx
* Sibling, spouse, altruistic
* Typically a kidney Tx

Note - Cadaveric transplants have worse outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In a kidney transplant, where is the new kidney placed?

A

Kidney transplanted into the right fossa

Transplants plumbed into the pelvis into Iliac vessels and bladder – why vessel assessment is important

17
Q

What from HLA profiling, what other imunnological tests/assessments must be performed prior to transplantation?

A

Blood group (ABO) compatible (RIE now has an ABO incompatible programme)

Immunological ‘X-match negative’ - checking whether HLA anitbodies are present in the recipient

18
Q

How is a immunological X-match carried out?

A

Cross match – does the patient (recipient) have any antibodies against the HLA molecules on the donors tissue

How?
1. We get the serum from recipient and donor cells from the donor
2. Add complement source which kills and green dye that enters dead cells.
3. If the antibody binds, the dye enters into the dead cells and becomes fluorescent green.

Note - Nowadays we use flowcytometry for cross-matching

19
Q

Why would a patient have anti-HLA antibodies against the donor’s cells?

A

Why should a patient waiting for a transplant have anti-HLA antibodies – we’re always being exposed to foreign HLA molecules.

About 30% of patients on waiting list have these anti-HLA

20
Q

What are some reasons why people would have high levels of anti-HLA antibodies?

A

Some patients are highly sensitised and exhibit high levels of cytotoxic Abs to many HLA antigens that may be derived from:

  1. Previous transfusions (WBC filtered)
  2. Pregnancies (foetus expresses paternal HLA molecules – recognized by mother)
  3. Previous Transplantation
21
Q

What is a method used to assess the level of HLA anitbodies in a patient?

A

Luminex HLA antibody detection

Careful way of assess the presence and level of HLA antibodies

  1. Using large number of beads with many different types of HLA’s.
  2. Presence of corresponding antibody will bind to the HLA antigen.
  3. Addition of secondary antibody will result in fluorescence.
22
Q

If kidney transplant is really needed, is there a way to overcome the problems possed by the presence of HLA antibodies?

A

If kidney transplant is really needed it is possible to desensitize the patient by removing the Anti-HLA antibody by plasma exchange

23
Q

What are the different categories of transplant rejection?

A
  • Hyperacute rejection (should not happen)
  • Acute rejection
  • Chronic rejection
24
Q

What happens in hyperacute kidney rejection?

A

Occurs when the Tx carries antigens to which the recipient is already sensitised – antibodies against transplant organ are already present.

Cytotoxic antibodies bind endothelial cells and induces complement activation, platelet aggregation and intravascular thrombus formation

The Tx is often destroyed ‘on the operating table’

25
Q

What are the features acute kidney rejection?

A

Mediated by cells or antibodies

Features – increase in creatinine (exclude the other potential variables that might be causing a rise in creatinine – list shown), reduced urine output, tender transplant and fever

Important to exclude…
* Dehydration (clinical examination, BP, weight)
* Renal obstruction (ultrasound)
* Vascular catastrophe (Doppler)
* Drug toxicity (tacrolimus levels – immunosuppressant – nephrotoxic)

Once those variables have been excluded, we need a kidney biopsy

26
Q

What are some histological features we observe in acute kidney rejection?

A
  1. Immune cell infiltration - T-cell and macrophages
  2. Tubular damage - tubulitis
  3. Vascular rejection - with also large vessel involvement
  4. If antibody mediated - we can see C4d desposition (immune footprint) - associated with inflammation (capillaritis)
27
Q

What is the treatment of acute kidney rejection?

A
  1. Corticosteroids - High dose methyl prednisolone (anti-inflammatory, kills lymphocyte etc) – normal action
  2. Change to more potent immunosuppressive agent or an increased dose
  3. ‘Anti-T cell’ antibody (increased risk of infection, tumours)
  4. Plasma exchange (severe acute Ab mediated rejection) – especially for antibody mediated rejection – attempt to remove antibodies
28
Q

What are the features of chronic kidney rejection? What do we need to exclude?

A

Features:
* Progressive renal dysfunction
* Interstitial fibrosis (fibrillar collagen deposition) and vascular disease on renal biopsy

Need to exclude:
* Recurrent disease (membranous nephropathy, mesangiocapillary glomerulonephritis - MCGN)
* Obstruction (ultrasound)
* Renal artery stenosis (Doppler of renal artery +/- MRI angiography)

29
Q

What is the pathogenesis of chronic rejection?

A

Multifactorial - immune and non-immune mechanisms

30
Q

What are factors that increase the risk of chronic rejection?

A
  • Increased HLA mismatch (1-2-1 vs 0-0-1)
  • Previous acute rejection
  • Poor drug compliance (low tacrolimus levels)
  • Prolonged cold ischaemia time (CIT) of kidney prior to surgery (CIT of living donor &laquo_space;cadaveric donor)

Other factors shown on image…

31
Q

What does the management of chronic kidney rejection look like?

A
  • No specific treatment available for it
  • Most people will eventually require dialysis and potentially further transplant
  • Optimize immunosuppression
  • Proactive treatment of blood pressure, lipids and proteinuria
32
Q

How do we prevent infection when people are on immunosuppresants?

A

Increased risk of infeciton using immunosuppresants

Bacteria Infection
* urinary tract infection, chest infection
* prophylactic cotrimoxazole (antibiotics)

Viral
* CMV, herpes virus, parvo virus, BK virus (causes renal dysfunction)
* prophylactic valgancyclovir if recipent CMV –ve and donor CMV +ve – prevents acute CMV disease

Potential increased risk for TB – may require prophylactic treatment

33
Q

Example BK Virus infection following immunosuppresion - how to treat?

A

Big abnormal cells – infected by BK virus

Treatment is to reduce immunosuppression
to facilitate anti-viral immunity

34
Q

Are tumours more common following immunosuppresion?

A

Increase risk of tumours in patients that are immunosuppressed for a long term

Examples…
- Skin cancers common – UV block, avoid sun and skin surveillance
- Post transplant lymphoproliferative disorder – tumour that is secondary to infection with Epstein barr virus – reduce immunosuppression and may need chemotherapy

35
Q

What are some side effects associated with calcineurin inhibitors and steroids?

A
  • Calcineurin inhibitors are nephrotoxic! Plasma levels of tacrolimus are measured regularly
  • Increased risk of diabetes (due to steroids and CNI - tacrolimus)
  • Hypertension (steroids and CNI)
  • Osteoporosis (steroids)
36
Q

What does the future of transplants hold?

A
  • Transplanting across the barriers of species – genetically engineered pigs that are humanized
  • Tolerance induction – make the immune system tolerant to new organs – regulatory T-cells
  • Artificial engineering of kidneys using stem cells